Efficacy, adherence and tolerability of once daily tenofovir DF-containing antiretroviral therapy in former injecting drug users with HIV-1 receiving opiate treatment: results of a 48-week open-label study

OBJECTIVE: To assess efficacy, adherence and tolerability of once daily antiretroviral therapy containing tenofovir disoproxil fumarate (DF) 300 mg in HIV-1-infected former injecting drug users receiving opiate treatment (IVDU). METHODS: European, 48-week, open-label, single-arm, multicenter study....

Descripción completa

Detalles Bibliográficos
Autores principales: Esser, S, Haberl, A, Mulcahy, F, Gölz, J, Lazzarin, A, Teofilo, E, Vera, J, Körber, A, Staszewski, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3400973/
https://www.ncbi.nlm.nih.gov/pubmed/22024421
http://dx.doi.org/10.1186/2047-783X-16-10-427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3400973/
https://www.ncbi.nlm.nih.gov/pubmed/22024421
http://dx.doi.org/10.1186/2047-783X-16-10-427

Ejemplares similares